NICOX SA (ALCOX.PA) Fundamental Analysis & Valuation

EPA:ALCOXFR0013018124

Current stock price

0.407 EUR
0 (0%)
Last:

This ALCOX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALCOX.PA Profitability Analysis

1.1 Basic Checks

  • ALCOX had negative earnings in the past year.
  • In the past 5 years ALCOX always reported negative net income.
  • ALCOX had a negative operating cash flow in each of the past 5 years.
ALCOX.PA Yearly Net Income VS EBIT VS OCF VS FCFALCOX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -185.23%, ALCOX is doing worse than 88.89% of the companies in the same industry.
Industry RankSector Rank
ROA -185.23%
ROE N/A
ROIC N/A
ROA(3y)-53.63%
ROA(5y)-42.36%
ROE(3y)-268.82%
ROE(5y)-176.47%
ROIC(3y)N/A
ROIC(5y)N/A
ALCOX.PA Yearly ROA, ROE, ROICALCOX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

  • ALCOX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCOX.PA Yearly Profit, Operating, Gross MarginsALCOX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

3

2. ALCOX.PA Health Analysis

2.1 Basic Checks

  • ALCOX has more shares outstanding than it did 1 year ago.
  • ALCOX has more shares outstanding than it did 5 years ago.
  • ALCOX has a worse debt/assets ratio than last year.
ALCOX.PA Yearly Shares OutstandingALCOX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALCOX.PA Yearly Total Debt VS Total AssetsALCOX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ALCOX has an Altman-Z score of -58.81. This is a bad value and indicates that ALCOX is not financially healthy and even has some risk of bankruptcy.
  • ALCOX's Altman-Z score of -58.81 is on the low side compared to the rest of the industry. ALCOX is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -58.81
ROIC/WACCN/A
WACCN/A
ALCOX.PA Yearly LT Debt VS Equity VS FCFALCOX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 10.66 indicates that ALCOX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 10.66, ALCOX belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
  • ALCOX has a Quick Ratio of 10.66. This indicates that ALCOX is financially healthy and has no problem in meeting its short term obligations.
  • ALCOX has a Quick ratio of 10.66. This is amongst the best in the industry. ALCOX outperforms 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 10.66
Quick Ratio 10.66
ALCOX.PA Yearly Current Assets VS Current LiabilitesALCOX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

6

3. ALCOX.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 22.64% over the past year.
  • The Revenue has grown by 13.85% in the past year. This is quite good.
  • Measured over the past years, ALCOX shows a small growth in Revenue. The Revenue has been growing by 2.77% on average per year.
EPS 1Y (TTM)22.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.98%
Revenue 1Y (TTM)13.85%
Revenue growth 3Y2.8%
Revenue growth 5Y2.77%
Sales Q2Q%-74.85%

3.2 Future

  • ALCOX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.75% yearly.
  • The Revenue is expected to grow by 102.03% on average over the next years. This is a very strong growth
EPS Next Y96%
EPS Next 2Y58.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year230%
Revenue Next 2Y102.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALCOX.PA Yearly Revenue VS EstimatesALCOX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ALCOX.PA Yearly EPS VS EstimatesALCOX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8 -1

4

4. ALCOX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALCOX. In the last year negative earnings were reported.
  • ALCOX is valuated cheaply with a Price/Forward Earnings ratio of 3.04.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALCOX indicates a rather cheap valuation: ALCOX is cheaper than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, ALCOX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.04
ALCOX.PA Price Earnings VS Forward Price EarningsALCOX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCOX.PA Per share dataALCOX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALCOX's earnings are expected to grow with 58.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.75%
EPS Next 3YN/A

0

5. ALCOX.PA Dividend Analysis

5.1 Amount

  • No dividends for ALCOX!.
Industry RankSector Rank
Dividend Yield 0%

ALCOX.PA Fundamentals: All Metrics, Ratios and Statistics

NICOX SA

EPA:ALCOX (4/24/2026, 7:00:00 PM)

0.407

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)04-28
Inst Owners4.12%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap36.00M
Revenue(TTM)3.32M
Net Income(TTM)-27.06M
Analysts84.44
Price Target1.53 (275.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.04
P/S 10.86
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)0.13
Fwd EY32.9%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -185.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.63%
ROA(5y)-42.36%
ROE(3y)-268.82%
ROE(5y)-176.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.66
Quick Ratio 10.66
Altman-Z -58.81
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.98%
EPS Next Y96%
EPS Next 2Y58.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.85%
Revenue growth 3Y2.8%
Revenue growth 5Y2.77%
Sales Q2Q%-74.85%
Revenue Next Year230%
Revenue Next 2Y102.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-106.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.32%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NICOX SA / ALCOX.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NICOX SA (ALCOX.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCOX.PA.


What is the valuation status for ALCOX stock?

ChartMill assigns a valuation rating of 4 / 10 to NICOX SA (ALCOX.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for NICOX SA?

NICOX SA (ALCOX.PA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for NICOX SA?

The Earnings per Share (EPS) of NICOX SA (ALCOX.PA) is expected to grow by 96% in the next year.